September 2019

The FDA’s regulation of medicinal cannabidiol containing products is an ongoing work in progress. However, the FDA’s recent spate…

The Centers for Medicare and Medicaid Services (“CMS”) published its annual proposed rule detailing changes to the Medicare…

ResMed recently announced that it reached a tentative settlement agreement with the DOJ in conjunction with an investigation…

Earlier this month, Senator Chuck Grassley sent a letter to Attorney General William Barr, expressing concern over the Department…

n July 2019, the Department of Justice announced a False Claims Act suit filed against Life Spine, Inc., for violations of the…

On September 16, 2019, Policy & Medicine editor Thomas Sullivan presented an interactive working session during the 17th…

A federal judge in Boston recently overturned the convictions of two former NECC executives who had been convicted of defrauding…

A supposed draft plan summary to lower drug prices by House Speaker Nancy Pelosi has been circulating around Capitol Hill…

The first opioid case to go trial has just concluded in Oklahoma with J&J as the sole defendant. This case is important for…

The Department of Health and Human Services (HHS) Office of the Inspector General (OIG) recently posted its findings following a…